Is Amgen Inc (AMGN) a good stock to buy?
In the past three months, Amgen insiders have not sold or bought any company stock. Only 0.36% of the stock of Amgen is held by insiders. 74.95% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
What are analysts'1 year price targets for Amgen's stock?
20 analysts have issued 1 year price objectives for Amgen's stock. Their predictions range from $189.00 to $243.00. On average, they expect Amgen's stock price to reach $217.29 in the next twelve months. This suggests a possible upside of 6.9% from the stock's current price.
What was Amgen’s price move in the latest trading session?
Amgen (AMGN) closed at $229.21 in the latest trading session, marking a +0.16% move from the prior day. © 2022 Yahoo. All rights reserved.
Who sold AGN stock in the last quarter?
AGN stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Janus Henderson Group PLC, King Street Capital Management L.P., Iridian Asset Management LLC CT, Baupost Group LLC MA, BlackRock Inc., BlackRock Inc. and Invesco Ltd..
How were Allergan's earnings last quarter?
Allergan plc (NYSE:AGN) issued its quarterly earnings results on Monday, February, 10th. The company reported $5.22 earnings per share for the quar...
Is Allergan a good dividend stock?
Allergan(NYSE:AGN) pays an annual dividend of $2.96 per share and currently has a dividend yield of 1.53%. The dividend payout ratio of Allergan is...
Who are Allergan's key executives?
Allergan's management team includes the following people: Mr. Brenton L. Saunders , Chairman, Pres & CEO (Age 49) Mr. William Meury , Exec. VP...
Who are some of Allergan's key competitors?
Some companies that are related to Allergan include Johnson & Johnson (JNJ) , Eli Lilly and (LLY) , Pfizer (PFE) , AbbVie (ABBV) , Merck & Co....
What other stocks do shareholders of Allergan own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Allergan investors own include CA (CA) , Endologix (ELGX)...
What is Allergan's stock symbol?
Allergan trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGN."
How much money does Allergan make?
Allergan (NYSE:AGN) has a market capitalization of $0.00 and generates $16.09 billion in revenue each year. The company earns $-5.27 billion in net...
How many employees does Allergan have?
Allergan employs 17,400 workers across the globe.
What is Allergan's official website?
The official website for Allergan is www.allergan.com .
Has Aegon NV (AEG) Outpaced Other Finance Stocks This Year?
How many specialists does Aegon Asset Management have?
Here is how Aegon NV (AEG) and Bank of America (BAC) have performed compared to their sector so far this year.
When will Aegon transition to zero emissions?
Aegon Asset Management has strengthened its Responsible Investment Team with three new appointments, bringing the team to 17 specialists.
Will Aegon repurchase common shares in 2021?
The Hague, November 2, 2021 - Aegon announces today that it has committed to transition its EUR 156 billion general account investment portfolio to net-zero greenhouse gas emissions by 2050. This is an important step in the strengthening of Aegon’s group-wide approach towards corporate sustainability. In this context, Aegon will join the Net-Zero Asset Owner Alliance, a UN-convened group of institutional investors committed to transitioning their portfolios to net-zero greenhouse gas emissions.
What is fair value in accounting?
THE HAGUE, Netherlands, September 17, 2021--Regulatory News: Aegon announced today that it will repurchase common shares for an amount of EUR 96 million to neutralize the dilutive effect of its 2021 interim dividend paid in shares. These shares will be held as treasury shares and will be used to pay future dividends in shares.
When will AEG earnings call end?
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
The Zacks Analyst Blog Highlights NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen
AEG earnings call for the period ending September 30, 2021.
AMGEN ISSUES INAUGURAL GREEN BOND TO ADVANCE ESG GOALS
NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen are included in this blog.
What is MarketBeat community ratings?
Amgen (NASDAQ:AMGN) today announced the issuance of its inaugural $750 million green bond, with a 3.000% semi-annual coupon and maturing in 2029, to advance the environmental goals that are part of Amgen's environmental, social and governance (ESG) framework.
What is the dividend payout ratio of Amgen?
MarketBeat's community ratings are surveys of what our community members think about Amgen and other stocks. Vote “Outperform” if you believe AMGN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AMGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
How much does Amgen make?
Amgen does not yet have a strong track record of dividend growth. The dividend payout ratio of Amgen is 42.41%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amgen will have a dividend payout ratio of 39.09% next year.
How much of Amgen stock is held by institutions?
Amgen has a market capitalization of $140.58 billion and generates $25.42 billion in revenue each year. The medical research company earns $7.26 billion in net income (profit) each year or $16.60 on an earnings per share basis.
Where is Amgen located?
74.95% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
What is the ticker symbol for Amgen?
Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company can be reached via phone at (805) 447-1000, via email at [email protected], or via fax at 805-447-1010.
What is Amgen's FY 2021 earnings?
Amgen trades on the NASDAQ under the ticker symbol "AMGN."
What is Neulasta used for?
Amgen updated its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided EPS guidance of $16.500-$17.100 for the period, compared to the Thomson Reuters consensus estimate of $16.430. The company issued revenue guidance of $25.80 billion-$26.20 billion, compared to the consensus revenue estimate of $26.01 billion.
What is the Amgen valuation method?
In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.
What is key stats?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Where is Amgen headquartered?
Key stats. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
What is the company name of Algernon Pharmaceuticals?
Listed exchange for this security. NASDAQ. About. . . Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks , California, in 1980.
What is the peak stimulation period for Algernon?
VANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough. The purpose of this 20-patient proof-of-concept Phase 2 human trial is to determine the
What are forward-looking statements?
(CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has established the optimum peak stimulation period of 6 hours for neuron out growth by AP-188 (“N,N-Dimethyltryptamine” or “DMT”) in its pre-clinical in vitro study conducted by Charles River Laboratories. Algernon also confirms that the increased gr
How long after DMT infusion can blood be detected?
Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties.
When will Algernon start clinical trials?
Importantly, the authors also confirmed that DMT administered intravenous infusion was clearly detectable in blood plasma measured 50 minutes after the initiation of DMT infusion, and in the brain tissue sampled upon the termination of the experimental protocol.
Does IL-6 cause fibrosis?
Algernon plans to be the first company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial in Q4 2021. “This study is further evidence that DMT must be investigated as a possible treatment for stroke,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals.
Is memantine a class effect?
IL-6 can promote fibrosis by driving chronic inflammation and is elevated in patients with IPF.1 Blockade of IL-6 has been shown to attenuate pulmonary fibrosis in a mouse model.2 The effects of Ifenprodil on IL-6 may be helpful in better understanding its potential role as a possible therapeutic treatment for IPF.
